Skip to content
Explore the latest in technology, digital marketing trends,…

Zimbabwe Rejects ‘Lopsided’ US Health Aid Deal Over Data Concerns

Health aid illustration
The offered US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.

The decision became public after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".

An official spokesperson has since explained that the United States was seeking genetic material for scientific study and profit but was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged more negotiations to secure a deal acceptable to all parties so the nation's critical HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a comparable situation in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were raised about the security of Kenyans' medical information.

Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.

Based on statements, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"In essence, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our population should a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were upending systems previously set up through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.

"This mechanism is intended to ensure that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.

"We are open to further dialogue with our American counterparts on how future collaboration could be designed in a way that respects the sovereignty and dignity of both nations."

Medical Community Response

Medical experts stated it recognised the government's concerns, but suggested that negotiations must proceed since a large portion of the country's Aids initiatives relied on international support.

"In cases where technical issues exist, such as those involving information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it added.

The halted deal highlights the continuing challenges between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.

Written by

Caleb Velazquez

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on business and society.

BlogNetPlus UK

Type to search articles.